MedrivaPeptide Intelligence
Profile

Somatropin (recombinant HGH): Evidence and Safety (2026)

Profile page for Somatropin (recombinant HGH): Evidence and Safety (2026). Evidence grade: strong.

Statusapproved
EvidenceStrong
Reviewed2026-06-05
Editorial review: Medriva pages are written by named contributors, reviewed by clinical or subject-matter experts, and updated as evidence or regulatory status changes.

Somatropin (recombinant HGH): Evidence, Side Effects, and Regulatory Status (2026)

Somatropin (recombinant HGH) is FDA-approved. Evidence grade: strong. This page is clinically reviewed.

TL;DR / Quick Facts

Somatropin (recombinant HGH) is Somatropin is recombinant human growth hormone (HGH). FDA-approved for GH deficiency in children and adults, Turner syndrome, Prader-Willi, chronic renal insufficiency, idiopathic short stature, and other indications. Multiple brand names (Genotropin, Humatrope, Norditropin, Omnitrope, Saizen). FDA status: FDA-approved. Typical use cases: muscle growth, longevity, anti aging, fitness. Evidence grade: strong. Dosing is per the FDA label — set by your clinician. Common side effects: see below. Medriva editorial stance: follow the FDA label; do not use off-label without clinical supervision.

What it is

Somatropin (recombinant HGH) is a member of the Recombinant human growth hormone class. Somatropin is identical in sequence to endogenous human GH. It binds the GH receptor, stimulating IGF-1 production in the liver and downstream anabolic effects.

What the evidence says

Evidence for Somatropin (recombinant HGH) is strong. Multiple phase 3 trials and post-market data support the labeled indications.

[Detailed evidence breakdown in the corresponding claim or pillar pages is linked at the bottom of this page.]

What it's used for

Commonly discussed uses of Somatropin (recombinant HGH):

  • Muscle Growth — strong evidence.
  • Additional uses listed in the linked use-case hubs; evidence varies by indication.

For the full list, see the linked use-case hubs below.

Typical dosing

Somatropin Overview dosing is determined by the approved label, indication, comorbidities, current medications, and clinician judgment. Medriva does not publish individualized dosing instructions or titration schedules. Review the current prescribing information and make changes only with a licensed clinician.

Side effects and risks

  • Common: Side effects vary by compound and indication; review the approved label or profile-specific safety data with a clinician.
  • Serious: Seek urgent care for severe allergic symptoms, chest pain, severe abdominal pain, persistent vomiting, or other severe reactions.
  • Long-term unknowns: For non-approved or research-use compounds, long-term human safety data may be limited.

Regulatory status

  • FDA-approved use(s): Multiple — GH deficiency (pediatric and adult), Turner syndrome, Prader-Willi, SGA, ISS, chronic renal insufficiency, others. Each brand has its own label.
  • Compounded availability: see 503A vs 503B explainer
  • Research-use-only (RUO) availability: n/a
  • Banned in sport: see WADA & sports explainer

Cost and access

Somatropin (recombinant HGH) is available by prescription; see the cost page for the relevant indication. For pricing, see our cost pages or the GLP-1 price/supply tracker where applicable.

Who it might be appropriate for

Adults with a relevant diagnosed condition or clinical goal, under the supervision of a licensed clinician, who have no contraindications. Somatropin (recombinant HGH) is not for self-experimentation.

Who should not use it

Contraindications vary by compound, indication, pregnancy status, comorbidities, and current medications. For the full list, see the contraindications checklist and discuss with your clinician.

Medriva editorial stance

We describe the literature. We do not promote Somatropin (recombinant HGH) as a cure, treatment, or performance enhancer. We do not recommend it for self-experimentation. We do recommend that readers (a) understand the evidence grade (strong), (b) understand the regulatory status (FDA-approved), and (c) discuss with a licensed clinician before acting.

How to talk to a clinician

See our guide on how to talk to a clinician for a templated conversation.

Frequently Asked Questions

Is Somatropin (recombinant HGH) FDA-approved?

FDA-approved. See the regulatory status section above for details.

Does Somatropin (recombinant HGH) work for muscle growth?

Evidence is strong. See the linked use-case hub for the full breakdown.

What are the side effects?

See the side effects section above. Discuss with your clinician.

How much does Somatropin (recombinant HGH) cost?

See the cost pages or the GLP-1 price/supply tracker where applicable.

Can I buy Somatropin (recombinant HGH) online?

By prescription only. Medriva does not sell peptides.

Author + Clinical reviewer

Author: Daniel Arora, MPH Clinical reviewer: Jonathan Reeves, MD Last reviewed: 2026-06-05

Next steps

  • Review the evidence grade and regulatory status before making decisions about Somatropin Overview.
  • Bring this page to a licensed clinician if you are discussing benefits, risks, or alternatives.
  • Subscribe to the Medriva Peptide Brief for evidence and regulatory updates.

Related use-case hubs

Related comparisons

Editorial process

This page follows the Medriva Editorial Policy and the Clinical Review Methodology. Page last reviewed: 2026-06-05. Author: Daniel Arora, MPH. Clinical reviewer: Jonathan Reeves, MD.

Current source updates

For new regulator actions, compounding-policy changes, warning letters, shortage updates, and sports-rule changes, review the Peptide Tracker before relying on older summaries.